Disc Medicine Inc. Total Liabilities
Disc Medicine Inc. total liabilities. Based on the latest financial reports, Disc Medicine Inc. (IRON) has total liabilities worth $90.91 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Disc Medicine Inc. (IRON) liquidity interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Disc Medicine Inc. (2020–2025)
Total liabilities of Disc Medicine Inc. from 2020 to 2025. This chart illustrates how Disc Medicine Inc.'s total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Disc Medicine Inc.'s assets to evaluate the company's liquid asset resilience ratio.
Disc Medicine Inc. Competitors by Total Liabilities
The table below lists competitors of Disc Medicine Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China International Marine Containers (Group) Co. Ltd
F:OCM
|
Germany | €100.23 Billion |
|
Gold Road Resources Ltd
AU:GOR
|
Australia | AU$382.05 Million |
|
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380
|
China | CN¥10.96 Billion |
|
Dalmia Bharat Limited
NSE:DALBHARAT
|
India | Rs-181.23 Billion |
|
Ardagh Metal Packaging SA
NYSE:AMBP
|
USA | $5.79 Billion |
|
OLAM GROUP LTD
F:K25
|
Germany | €31.78 Billion |
|
FRASERS PROPERTY
F:1IQ
|
Germany | €22.95 Billion |
|
Bandhan Bank Limited
NSE:BANDHANBNK
|
India | Rs1.83 Trillion |
Liability Composition Analysis (2020–2025)
This chart breaks down Disc Medicine Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IRON total asset value.
Liquidity & Leverage Metrics
Disc Medicine Inc. Total Liabilities Ratios Explained
Disc Medicine Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 24.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Disc Medicine Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Disc Medicine Inc. (2020–2025)
The table below shows the annual total liabilities of Disc Medicine Inc. from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $67.05 Million | +26.07% |
| 2024-12-31 | $53.19 Million | +132.51% |
| 2023-12-31 | $22.88 Million | -3.09% |
| 2022-12-31 | $23.61 Million | -84.93% |
| 2021-12-31 | $156.61 Million | +418.93% |
| 2020-12-31 | $30.18 Million | -- |
About Disc Medicine Inc.
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associ… Read more